Graves' Disease Associated with Goserelin Acetate
スポンサーリンク
概要
- 論文の詳細を見る
We describe a case of Graves' disease associated with goserelin acetate. A 47-year-old woman experienced thyrotoxicosis during the administration of goserelin acetate, a gonadotropin-releasing hormone (GnRH) -agonist. Since the TSH receptor-antibody was positive, and a thyroid scintigram showed diffuse goiter and high uptake, she was diagnosed as having Graves' disease. 26 months after treatment with thiamazole, she recovered. We speculate that the administration of goserelin acetate may be one of the triggers of Graves' disease.
- 長崎大学の論文
著者
関連論文
- Transient Appearance of Lactate Dehydrogenase (LDH)-linked Immunoglobulin and Thyroid Dysfunction at the Postpartum Period
- Anti-Thyroid Drug-Induced ANCA-Associated Vasculitis: A Case Report and Review of the Literature
- Graves' Disease Associated with Goserelin Acetate
- Graves' Disease Development During Sizofiran Treatment
- Graves' Disease Development During Sizofiran Treatment.